WBBA Board of Directors

Directors

• James Bianco, M.D., President & CEO, Cell Therapeutics, Inc.
• D. William Brady, Jr., Senior Manager, KPMG LLP
• Bruce L. A. Carter, Ph.D., President and CEO, ZymoGenetics, Inc.
• Thomas Clement, President & CEO, Pathway Medical Technologies, Inc.
• Rob Derry, Investment Advisor, Silicon Valley Bank
• Ed Drosdick, Partner, Moss Adams LLP
• Christopher J. Elias, M.D., MPH, President, PATH - Program for Appropriate Technology in Health
• Beth Etscheid, Ph.D., Director of Licensing, Washington Research Foundation
• Jack Faris, Ph.D., President, Washington Biotechnology & Biomedical Association
• H. Perry Fell, Ph.D., President & CEO, NanoString Technologies
• Eric Fogel, MBA Biotech Club, University of Washington
• Alan D. Frazier, Founder and Managing Partner, Frazier Healthcare Ventures
• Alan Fuhrman, Senior Vice President & CFO, Sonus Pharmaceuticals, Inc.
• Linda Gainer, Vice President, External Relations and Communications, Fred Hutchinson Cancer Research Center
• David Galas, VP, CSO Biological & Life Science, Battelle Seattle Research Center
• John Gardner, Vice President for Economic Development and Extension, WSU
• Brett V. Gaspers, Managing Director, Objective Insights
• Mitchell H. Gold, CEO, Dendreon Corporation
• James Gore, Vice President, Pacific Northwest Diabetes Research Institute (PNRI)
• Stephen M. Graham, Partner, Fenwick & West LLP
• Douglas R. Hansmann, General Manager, EKOS Corporation
• John F. Harris, President & CEO, NeuroVista Corporation
• Karen Hedine, President & CEO, Micronics, Inc.
• James B. Hendricks, PhD, President, Seattle Children's Hospital Research Institute
• Larry Herron, Vice President for Development, Institute for Systems Biology
• John Hinson, President & CEO, Cardiac Science Corporation
• Allan Jones, Ph.D., Chief Scientific Officer, Allen Institute for Brain Science
• Jim Karkanias, Senior Director of Applied Research and Technology, Health Solutions Group, Microsoft
• Kevin F. Kelly, Shareholder, Heller Ehrman Attorneys
• Bill Kimmerly, PhD, Director, Facilities for Systems Biology & Applications, Pacific Northwest National Laboratory
• Rick Klausner, Partner, The Column Group
• Deborah Knutson, President, EDC of Snohomish County
• Michael Kranda, Director of Biotechnology Venture Investments, Vulcan Inc.
• Thong W. Le, Managing Director, WRF Capital
• Bill Lewis, President & CEO, Lease Crutcher Lewis
• Jim Lisbakken, Partner & Chair of Life Sciences Practice Group, Perkins Coie LLP
• Tim Martin, Director of State Government Relations, Amgen
• Margaret McCormick, Ph.D., Partner, Integra Ventures
• A. Bruce Montgomery, M.D., Senior VP, Gilead Respiratory Therapeutics
• Jack Nagan, Executive Director Benaroya Research Institute at Virginia Mason and VP Research, Virginia Mason Medical Center
• H. Stewart Parker, President & CEO, Targeted Genetics Corporation
• Jens Quistgaard, President & CEO, Liposonix, Inc.
• Erick Rabins, Vice President, Allied Minds, Inc.
• Gregory Sessler, Chief Financial Officer, Spiration, Inc.
• Clay B. Siegall, Ph.D., President & CEO, Seattle Genetics, Inc.
• John Steel, Partner, DLA Piper US LLP
• Ken Stuart, Director & President, Seattle Biomedical Research Institute
• Terry Sweeney, Senior Vice President Quality & Regulatory Affairs, Philips Ultrasound
• Peter Thompson, M.D., President & CEO, Director, Trubion Pharmaceuticals, Inc.
• Carl Weissman, President & CEO, Accelerator Corporation
• Susan Wray Spraitzar, DDS, JD, Senior Director of Regulatory & Intellectual Property, Light Sciences Oncology, Inc.

Back to About WBBA

Washington Biotechnology & Biomedical Association
2324 Eastlake Avenue East, Suite 500
Seattle, WA 98102
Phone: 206.732.6700
Fax: 206.732.6701
E-mail: admin@washbio.org